Holen Sie sich die Stockscreener-App
2.25
7.14%
0.15
Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
10.89%
4.158
|
4.666 | 4.443 | 4.339 | 5.111 |
| Depreciation and Amortization |
12.50%
0.035
|
0.04 | 0.053 | 0.047 | 0.049 |
| Operating Income/Loss |
10.89%
-4.158
|
-4.666 | -4.443 | -4.339 | -5.111 |
| Nonoperating Income/Loss |
0.00%
0.202
|
0.202 | 0.278 | - | -0.078 |
| Income/Loss From Continuing Operations Before Tax |
11.38%
-3.956
|
-4.464 | -4.165 | -4.166 | -5.189 |
| Income/Loss From Continuing Operations After Tax |
11.38%
-3.956
|
-4.464 | -4.165 | -4.166 | -5.189 |
|
Net Income/Loss
|
11.38%
-3.956
|
-4.464 | -4.165 | -4.166 | -5.189 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,255%
10.17
|
0.19 | 10.15 | 10.06 | 8.143 |
| Diluted Average Shares |
5,255%
10.17
|
0.19 | 10.15 | 10.06 | -0.956 |
| Basic Earnings Per Share |
11.36%
-0.39
|
-0.44 | -0.41 | -0.41 | -0.64 |
| Diluted Earnings Per Share |
11.36%
-0.39
|
-0.44 | -0.41 | -0.41 | -0.62 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):